3D Lung Epithelium via FGF WNT RA Signaling

Solution Overview

Problem

Current methods for differentiating human pluripotent stem cells into lung lineages lack predictive power due to gaps in understanding human lung development, particularly in maintaining distal tip progenitor cells and species-specific differences between mouse and human lung development.

Innovation Solution

The use of synergistic activation of FGF, WNT, and RA signaling pathways to promote the growth and maintenance of SOX9+/SOX2+ distal lung-bud progenitor cells in vitro, specifically in human pluripotent stem cell-derived ventral-anterior foregut spheroids, to induce 3-dimensional lung-like epithelium.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional differentiation methods are used to generate lung lineages from human pluripotent stem cells, then lung tissue can be obtained, but the predictive power is limited due to gaps in understanding human lung development

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent applies parameter changes by systematically varying signaling pathway activation levels (WNT, FGF, RA) to optimize the differentiation process. By adjusting the parameters of signaling molecule concentrations and timing, the method achieves more reliable generation of distal tip progenitor cells with improved predictive power for human lung development

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs feedback mechanisms by monitoring the expression of specific markers (SOX2, SOX9, NKX2-1) and adjusting differentiation conditions accordingly. This feedback loop allows refinement of the differentiation protocol to better predict and replicate human lung development processes

Inventive Principle:
Principle #23Feedback

2Loss of information

If mouse models are used to study lung development, then mechanistic insights can be gained, but species-specific differences limit the applicability to human lung development

Engineering Contradiction:
Core Design Contradiction:
Loss of informationVSAdaptability or versatility

Solution Approach 1:

The patent segments the differentiation process into distinct stages that can be independently optimized. By dividing the complex differentiation into manageable phases (definitive endoderm formation, foregut specification, distal tip progenitor generation), the method can incorporate human-specific parameters at each stage, improving applicability to human lung development while retaining mechanistic insights

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by implementing species-specific signaling conditions at different spatial and temporal points during differentiation. By tailoring the signaling environment to match human developmental requirements at specific stages, the method bridges the gap between mouse model insights and human applicability

Inventive Principle:
Principle #3Local quality

3Productivity

If distal tip progenitor cells are maintained in culture, then expansion of progenitor population is achieved, but maintaining the undifferentiated state becomes challenging

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent implements continuity of useful action by maintaining constant activation of WNT, FGF, and RA signaling pathways throughout the culture period. This continuous signaling prevents differentiation events that would otherwise occur during passaging and expansion, allowing sustained maintenance of the undifferentiated progenitor state while achieving population expansion

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent applies preliminary action by pre-establishing the optimal signaling environment before expansion begins. By pre-configuring the culture conditions with appropriate signaling molecule concentrations and preparing the extracellular matrix environment, the method prevents differentiation during subsequent expansion passages

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11857697B2Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof
Publication Date: 2024.01.02
  • US11857697B2 patent drawing
  • US11857697B2 patent drawing
  • US11857697B2 patent drawing

AI summary

The invention disclosed herein generally relates to methods and systems for growing, expanding and/or obtaining 3-dimensional lung-like epithelium comprising cells having SOX9 protein activity and SOX2+ protein activity. In particular, the invention disclosed herein relates to methods and systems for growing human cells having SOX9 protein activity and SOX2+ protein activity in vitro, and for promoting pluripotent stem cell derived ventral-anterior foregut spheroid tissue into 3-dimensional lung-like epithelium comprising cells having SOX9 protein activity and SOX2+ protein activity.